108
Participants
Start Date
December 31, 2012
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
SAMe 1000 mg
1000 mg dose group: one 500 mg capsule fasting in the morning and one 500 mg capsule before dinner
SAMe 1500 mg
1500 mg dose group: two 500 mg capsules fasting in the morning and one 500 mg capsule before dinner
SAMe 2000 mg
2000 mg dose group: two 500 mg capsules fasting in the morning and two 500 mg capsules before dinner
Site Reference ID 93917, Hanover
Site Reference ID 93896, Pessac
Site Reference ID 93913, Montpellier
Site Reference ID 93895, Angers
Site Reference ID 93953, Bonn
Site Reference ID 93918, Mainz
Site Reference ID 93954, Frankfurt
Site Reference ID 93933, Homburg
Site Reference ID 93915, Paris
Site Reference ID 93893, Paris
Site Reference ID 93935, Freiburg im Breisgau
Site Reference ID 93914, Amiens
Site Reference ID 94014, Ulm
Site Reference ID 93894, Bobigny
Site reference ID ORG-000906, Moscow
Site reference ID ORG-000920, Rostov-on-Don
Site reference ID ORG-000901, Stavropol
Site reference ID ORG-000904, Samara
Site reference ID ORG-000900, Nizhny Novgorod
Site reference ID ORG-000907, Novosibirsk
Site reference ID ORG-000903, Omsk
Site reference ID ORG-000905, Krasnoyarsk
Site Reference ID 93916, Nice
Site Reference ID 93955, Halle
Site Reference ID 94015, Leipzig
Site reference ID/Investigator # 109455, Bydgoszcz
Site Reference ID 93958, Chorzów
Site Reference ID 93973, Krakow
Site Reference ID 93956, Lodz
Site Reference ID 93957, Mysłowice
Site Reference ID 93974, Warsaw
Site Reference ID 93975, Wroclaw
Lead Sponsor
Collaborators (1)
PPD Development, LP
INDUSTRY
Abbott
INDUSTRY